Detrusor Underactivity Clinical Trial
Official title:
The Prevalence and Clinical Presentation of Detrusor Underactivity and Its Urodynamic Characteristics
Verified date | April 2020 |
Source | Mutah University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Detrusor underactivity (DU) is a known disease of the muscles of the urinary bladder that defined as a weak contraction of the muscle resulting in a failure to achieve complete bladder emptying. Recently, DU as a cause of Lower Urinary Tract Symptoms in both men and women has been increasingly gaining attention. There is a major issue in differentiation of underactive bladder symptoms and other causes of lower urinary tract symptoms such as detrusor hyperactivity and impaired contractility (DHIC), hypersensitive bladder (HSB), detrusor overactivity (DO), bladder outlet obstruction (BOO) and Dysfunctional Voiding (DV). Urodynamics (UDS) is the standard diagnostic tool, it includes invasive recording of the pressure that is produced when the bladder muscle contracts via pressure sensors introduced in the urinary bladder through special types of urethral catheters. This study aims to determine the prevalence of DU along with its symptomatic and urodynamics (UDS) characteristics of DU in Jordanian population through a retrospective chart review.
Status | Completed |
Enrollment | 206 |
Est. completion date | March 25, 2020 |
Est. primary completion date | February 28, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 87 Years |
Eligibility |
Inclusion Criteria: - Patients underwent UDS from July 2016 to August 2019 Exclusion Criteria: - Patients with neurogenic bladder (NB) due to known underlying neurological disease, history of open pelvic surgery or major abdominal surgery, or using indwelling catheters or clean intermittent catheterization (CIC). |
Country | Name | City | State |
---|---|---|---|
Jordan | Istishari Urology Center (IUC) | Amman |
Lead Sponsor | Collaborator |
---|---|
Mutah University | Istishari Urology Center |
Jordan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prevalence of detrusor underactivity in Jordan | The proportion of patients with lower urinary tract symptoms found to be affected by Detrusor underactivity | 3 years | |
Primary | Symptomatic presentation of Detrusor underactivity | Arabic version of the International Prostate Symptom Score was used to assess the prevalence and severity of the symptoms that are associated with detrusor underactivity. The questionnaire includes 8 questions, the 1st 7 questions are about the urinary symptoms (Incomplete emptying, urinary frequency, intermittency, urgency, weak urine stream, straining and nocturia) and the 8th is about Quality of Life due to Urinary Symptoms. Each question concerning urinary symptoms allows the patient to choose one out of six answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic). The answers to the 8th question (quality of life) range from "delighted" to "terrible" or 0 to 6. | over one month period prior to clinical evaluation during the 3 years time period | |
Primary | Urodynamics parameters | Urodynamics is a series of tests conducted in an outpatient setting that evaluates the function of the urinary bladder, including physiological parameters of how completely the bladder, sphincter and urethra are storing and releasing urine. These parameters are recorded by pressure sensors that are inserted into the bladder via special urinary catheters to measure the pressure that is generated during storing and releasing urine. The assessment of urodynamic variables is based on bladder capacity, presence of involuntary bladder muscle contractions, bladder volume at 1st sensation of bladder filling, bladder volumes at normal and strong desire for urination, detrusor pressure at maximum flow of urine during voiding, volume voided, and the post-void residual urine volume. All urodynamic testing was performed based on the International Continence Society standards. | Each test takes around 30-45 minutes, all urodymanics studies were performed during the study period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06452927 -
EEP in Patients With Urodynamically Proven DU/DA
|
N/A | |
Completed |
NCT04161183 -
Extracoporeal Shock Wave Therapy (ESWT) for the Treatment of Detrusor Underactivity/ Underactive Bladder (DU/UAB)
|
N/A | |
Completed |
NCT04543552 -
A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
|
||
Completed |
NCT05359484 -
Delta Q Value to Discriminate Detrusor Underactivity From Bladder Outlet Obstruction
|
Phase 2/Phase 3 | |
Completed |
NCT00441428 -
Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity
|
Phase 2 | |
Completed |
NCT05470751 -
GentleCathâ„¢ for Men Intermittent Catheter With FeelCleanâ„¢ Technology
|
||
Completed |
NCT04981080 -
DU and BOO in Women With and Without Symptoms of VD
|
||
Recruiting |
NCT06020963 -
Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding Efficiency
|
N/A | |
Completed |
NCT03175029 -
Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.
|
Phase 2 | |
Active, not recruiting |
NCT02193451 -
Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods
|
N/A |